Vivek Swarup

Vivek Swarup

Auto-generated profile, based on publicly available information

Vivek Swarup

Department of Neurobiology and Behavior, University of California Irvine

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 June 2023 in Cell Reports Methods
Verified
Journal Article
Open access
SMSamuel Morabito
Samuel Morabito
FRFairlie Reese
Fairlie Reese
NRNegin Rahimzadeh
Negin Rahimzadeh
EMEmily Miyoshi
Emily Miyoshi
VSVivek Swarup
Vivek Swarup
Biological systems are immensely complex, organized into a multi-scale hierarchy of functional units based on tightly regulated interactions between distinct molecules, cells, organs, and organisms. While experimental methods enable transcriptome-wide measurements across millions of cells, popular bioinformatic tools do not support systems-level analysis. Here we present hdWGCNA, a comprehensive framework for analyzing co-expression networks in high-dimensional transcriptomics data such as single-cell and spatial RNA sequencing (RNA-seq). hdWGCNA provides functions for network inference, gene module identification, gene enrichment analysis, statistical tests, and data visualization. Beyond conventional single-cell RNA-seq, hdWGCNA is capable of performing isoform-level network analysis using long-read single-cell data. We showcase hdWGCNA using data from autism spectrum disorder and Alzheimer’s disease brain samples, identifying disease-relevant co-expression network modules. hdWGCNA is directly compatible with Seurat, a widely used R package for single-cell and spatial transcriptomics analysis, and we demonstrate the scalability of hdWGCNA by analyzing a dataset containing nearly 1 million cells.

8 July 2021 in Nature Genetics
Verified
Journal Article
Closed access
PDF file
SMSamuel Morabito
Samuel Morabito
EMEmily Miyoshi
Emily Miyoshi
NMNeethu Michael
Neethu Michael
SSSaba Shahin
Saba Shahin
AMAlessandra Cadete Martini
Alessandra Cadete Martini
VSVivek Swarup
Vivek Swarup

7 October 2020 in Nature
Verified
Journal Article
Closed access
PDF file
YLYi Li
Yi Li
XHXuelian He
Xuelian He
RKRiki Kawaguchi
Riki Kawaguchi
YZYu Zhang
Yu Zhang
QWQing Wang
Qing Wang
ZHZhigang He
Zhigang He

14 June 2022 in Cell Reports
Verified
Journal Article
Open access
SSSepideh Kiani Shabestari
Sepideh Kiani Shabestari
SMSamuel Morabito
Samuel Morabito
EDEmma Pascal Danhash
Emma Pascal Danhash
AMAmanda McQuade
Amanda McQuade
JSJessica Ramirez Sanchez
Jessica Ramirez Sanchez
MBMathew Blurton-Jones
Mathew Blurton-Jones
Microglia are strongly implicated in the development and progression of Alzheimer’s disease (AD), yet their impact on pathology and lifespan remains unclear. Here we utilize a CSF1R hypomorphic mouse to generate a model of AD that genetically lacks microglia. The resulting microglial-deficient mice exhibit a profound shift from parenchymal amyloid plaques to cerebral amyloid angiopathy (CAA), which is accompanied by numerous transcriptional changes, greatly increased brain calcification and hemorrhages, and premature lethality. Remarkably, a single injection of wild-type microglia into adult mice repopulates the microglial niche and prevents each of these pathological changes. Taken together, these results indicate the protective functions of microglia in reducing CAA, blood-brain barrier dysfunction, and brain calcification. To further understand the clinical implications of these findings, human AD tissue and iPSC-microglia were examined, providing evidence that microglia phagocytose calcium crystals, and this process is impaired by loss of the AD risk gene, TREM2.

3 December 2018 in Nature Medicine
Verified
Journal Article
Closed access
PDF file
VSVivek Swarup
Vivek Swarup
FHFlora I. Hinz
Flora I. Hinz
JRJessica E. Rexach
Jessica E. Rexach
KNKen-Ichi Noguchi
Ken-Ichi Noguchi
HTHiroyoshi Toyoshiba
Hiroyoshi Toyoshiba
Daniel GeschwindDaniel Geschwind
Daniel Geschwind

22 November 2024 in Nature Genetics
Verified
Journal Article
Open access
PDF file
EMEmily Miyoshi
Emily Miyoshi
SMSamuel Morabito
Samuel Morabito
CHCaden M. Henningfield
Caden M. Henningfield
SDSudeshna Das
Sudeshna Das
NRNegin Rahimzadeh
Negin Rahimzadeh
VSVivek Swarup
Vivek Swarup
The pathogenesis of Alzheimer’s disease (AD) depends on environmental and heritable factors, with its molecular etiology still unclear. Here we present a spatial transcriptomic (ST) and single-nucleus transcriptomic survey of late-onset sporadic AD and AD in Down syndrome (DSAD). Studying DSAD provides an opportunity to enhance our understanding of the AD transcriptome, potentially bridging the gap between genetic mouse models and sporadic AD. We identified transcriptomic changes that may underlie cortical layer-preferential pathology accumulation. Spatial co-expression network analyses revealed transient and regionally restricted disease processes, including a glial inflammatory program dysregulated in upper cortical layers and implicated in AD genetic risk and amyloid-associated processes. Cell–cell communication analysis further contextualized this gene program in dysregulated signaling networks. Finally, we generated ST data from an amyloid AD mouse model to identify cross-species amyloid-proximal transcriptomic changes with conformational context.